Ledger.Open graph →
SEC Form D · filed January 11, 2022

Sorriso Pharmaceuticals, Inc

Offering
$31.4M
Sold
$21.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SANDY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Brian Dorsey · Houston, TXExecMichael Grey · Vista, CADirectorEdward Mathers · Boston, MADirectorCiara Kennedy, Ph.D · Sandy, UTExec · DirectorMark Chin · San Diego, CADirectorSusan Dube · San Diego, CAExecBrian Dorsey · Houston, TXExecMichael Grey · San Diego, CADirectorEdward Mathers · Cambridge, MADirectorCiara Kennedy, Ph.D · Sandy, UTExec · DirectorMark Chin · San Diego, CADirectorSusan Dube · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗